Square-wave adsorptive stripping voltammetric behaviour of entacapone at HMDE and its determination in the presence of surfactants

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 359, Issue 1-3, 2010, Pages 25-30

  Jain, Rajeev ^a   Yadav, Rajeev Kumar ^a   Dwivedi, Ashish ^a  

^a JIWAJI UNIVERSITY   (India)

Author keywords

Adsorptive stripping voltammetry; Entacapone; Hanging mercury dropping electrode; Pharmaceutical dosage forms; Solubilized systems; Surfactants

Indexed keywords

ANIONIC SURFACTANTS; CATIONIC SURFACTANTS; DYES; MERCURY (METAL); STRIPPING (DYES); VOLTAMMETRY;

ADSORPTIVE STRIPPING VOLTAMMETRY; BRITTON-ROBINSON BUFFER; CONTROLLED POTENTIAL ELECTROLYSIS; CORRELATION COEFFICIENT; DIFFERENTIAL PULSE VOLTAMMETRY; ENHANCEMENT EFFECTS; ENTACAPONE; LOWER LIMIT OF DETECTIONS; LOWER LIMIT OF QUANTIFICATIONS; NEUTRAL SURFACTANT; PH RANGE; PHARMACEUTICAL DOSAGE FORMS; PHARMACEUTICAL FORMULATION; REDUCTION CURRENT; REDUCTION PEAK; REDUCTION PROCESS; SOLUBILIZED SYSTEM; SQUARE-WAVE; SULPHATES; TWEEN-20; VOLTAMMETRIC;

DRUG PRODUCTS;

ADACAPONE; CETRIMIDE; DODECYL SULFATE SODIUM; ELECTROLYTE; ENTACAPONE; POLYSORBATE 20; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COULOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG DETERMINATION; DRUG FORMULATION; DRUG STRUCTURE; ELECTRICAL EQUIPMENT; ELECTROCHEMICAL ANALYSIS; ELECTROLYSIS; HANGING MERCURY DROP ELECTRODE; PH; PRIORITY JOURNAL; REDUCTION KINETICS;

EID: 77549085739     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2010.01.047     Document Type: Article

References (29)

1. ®, Novartis NDA 20-796/S-013 and S-012.
2. Najib J. PharmD, entacapone: a catechol-O-methyltransferase inhibitor for the adjunctive treatment of Parkinson's disease. Clinical Therapeutics 23 (2001) 802-832
3. Paija O., Laine K., Kultalahti E.R., Leinonen M., Huupponen R., Gordin A., and Reinikainen K. Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with sinemet CR. Clinical Europharmacology 28 (2005) 115-119
4. Perez R.A., Fernandez-Alvarez E., Nieto O., and Piedrafita F.J. Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols: kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione. Biochemical Pharmacology 45 (1993) 1973-1981
5. Holm K.J., and Spencer C.M. Entacapone: a review of its use in Parkinson's disease. Drugs 58 (1999) 159-177
6. Mannisto P.T., and Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of new selective COMT inhibitors. Pharmacological Reviews 51 (1999) 593-628
7. Kaakkola S. Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease. Drugs 59 (2000) 1233-1250
8. Rajeswari K.R., Sankar G.G., Rao A.L., and Rao J.V.N.S. A new spectrophotometric method for the determination of entacapone in pure and tablet dosage form. International Journal of Chemical Science 4 (2006) 694-696
9. Paim C.S., Gonalves H., Lange A., Miron D., and Steppe M. Validation of UV spectrophotometric method for quantitative determination of entacapone in tablets using experimental design of plackett-burman for robustness evaluation and comparison with HPLC. Analytical Letters 41 (2008) 571-581
10. Paim C.S., Goncalves H.M.L., Miron D., Sippel J., and Steppe M. Stability-indication LC determination of entacapone in tablets. Chromatographia 65 (2007) 595-599
11. Karlsson M., and Wikberg T. Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis 10 (1992) 593-600
12. Keski-Hynnila H., Raanaa K., Forsberg M., Mannisto P., Taskinen J., and Kostiainen R. Quantitation of entacapone glucuronide in rat plasma by on-line coupled restricted access media column and liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 759 (2001) 227-236
13. Ramakrishna N.V.S., Vishwottam K.N., Wishu S., Koteshwara M., and Chidambra J. High-performance liquid chromatography method for the quantification of entacapone in human plasma. Journal of Chromatography B 823 (2005) 189-199
14. Lehtonen P., Malkki-Laine L., and Wikberg T. Separation of the glucuronides of entacapone and its (Z)-isomer in urine by micellar electrokinetic capillary chromatography. Journal of Chromatography B 721 (1999) 127-134
15. Keski-Hynnila H., Raanaa K., Taskinen J., and Kostiiainen R. Direct analysis of nitrocatechol-type glucuronides in urine by capillary electrophoresis-electrospray ionisation mass spectrometry and tandem mass spectrometry. Journal of Chromatography B 749 (2000) 253-263
16. Abasq M.L., Courtel P., and Burgot G. Determination of entacapone by differential pulse polarography in pharmaceutical formulation. Analytical Letters 41 (2008) 56-65
17. Bard A.J., and Faulker L.R. Electrochemical Methods: Fundamentals and Applications (2002), John Wiley & Sons Inc., New York
18. Ibrahim F., El-Enany N., Ibrahim F., and El-Enany N. Anodic polarographic determination of ciclopirox olamine in pure and certain pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis 32 (2003) 353-359
19. Jain R., Dwivedi A., and Mishra R. Adsorptive stripping voltammetric behaviour of nortriptyline hydrochloride and its determination in surfactant media. Langmuir 25 (2009) 10364-10369
20. Jain R., Jadon N., and Radhapyari K. Adsorptive stripping voltammetric behavior and determination of anticholinergic agent oxybutynin chloride on a mercury electrode. Journal of Colloid and Interface Science 314 (2007) 572-577
21. Razak O.A. Electrochemical study of hydrochlorothiazide and its determination in urine and tablets. Journal of Pharmaceutical and Biomedical Analysis 34 (2004) 433-440
22. Jain R., Dwivedi A., and Mishra R. Voltammetric behaviour of cefdinir in solubilized system. Journal of Colloid and Interface Science 318 (2008) 296-301
23. Goyal R.N., Gupta V.K., and Chatterjee S. A sensitive voltammetric sensor for determination of synthetic corticosteroid triamcinolone, abused for doping. Biosensors and Bioelectronics 24 (2009) 3562-3568
24. 60-modified edge plane pyrolytic graphite electrode for the determination of dexamethasone in pharmaceutical formulations and human biological fluids. Biosensors and Bioelectronics 24 (2009) 1649-1654
25. Goyal R.N., Gupta V.K., and Chatterjee S. Simultaneous determination of adenosine and inosine using single-wall carbon nanotubes modified pyrolytic graphite electrode. Talanta 76 (2008) 663-669
26. Goyal R.N., Gupta V.K., and Chatterjee S. Electrochemical oxidation of 2,3-dideoxyadenosine at pyrolytic graphite electrode. Electrochimica Acta 53 (2008) 5354-5360
27. Goyal R.N., Gupta V.K., Bachheti N., and Sharma R.A. Electrochemical sensor for the determination of dopamine in presence of high concentration of ascorbic acid using a fullerene-c60 coated gold electrode. Electroanalysis 20 (2008) 757-764
28. Goyal R.N., Gupta V.K., Oyama M., and Bachheti N. Differential pulse voltammetric determination of paracetamol at nanogold modified indium tin oxide electrode. Electrochemistry Communications 7 (2005) 803-807
29. International Conference on Harmonisation, ICH Harmonised Tripartite Guideline, Text on Validation of Analytical Procedure. Federal Register 60 (1995) 112602